Evidence map›Paper›PMID 33671065›Full record

ArticleInternational journal of molecular sciences2021

George A Naclerio, Nader S Abutaleb, Marwa Alhashimi, Mohamed N Seleem, Herman O Sintim

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Inhibition of pathogenic bacterial carbonic anhydrases by monothiocarbamates.Journal of enzyme inhibition and medicinal chemistry · 2023
    Article
  8. Article
  9. Review
  10. Mechanistic Studies andJournal of medicinal chemistry · 2022
    Article
  11. Article
  12. Article
  13. Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

George A NaclerioChemistry Department, Institute for Drug Discovery, Purdue University, West Lafayette, IN 47907, USA.
Nader S AbutalebDepartment of Comparative Pathobiology, Purdue University College of Veterinary Medicine, West Lafayette, IN 47907, USA.ORCID 0000-0003-1730-4150
Marwa AlhashimiDepartment of Comparative Pathobiology, Purdue University College of Veterinary Medicine, West Lafayette, IN 47907, USA.
Mohamed N SeleemDepartment of Comparative Pathobiology, Purdue University College of Veterinary Medicine, West Lafayette, IN 47907, USA.
Herman O SintimChemistry Department, Institute for Drug Discovery, Purdue University, West Lafayette, IN 47907, USA.ORCID 0000-0002-2280-9359

Funding

Purdue Institute for Drug Discovery N/A
6 · The paper itself

Abstract

The Centers for Disease Control and Prevention (CDC) recognizes

Indexed as

Anti-Bacterial AgentsBenzamidesCell LineGonorrheaHumansListeria monocytogenesMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsNeisseria gonorrhoeaeOxadiazoles1,3,4-oxadiazoleAnti-Bacterial AgentsBenzamidesOxadiazoles1,3,4-oxadiazoleantibioticantimicrobial resistanceNeisseria gonorrhoeae

Identifiers

PMID33671065
PMCPMC7957578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.